Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer's Next Big Deal Will Generate Income For Novartis, Prevent Competitors' Initiative
Seeking Alpha
Friday, March 29, 2013 - 10:54am
tags:
Pfizer, Novartis, breast cancer, palbociclib
Tranzyme Pharma Announces Fourth Quarter and Full-Year 2012 Financial Results
Yahoo
Friday, March 29, 2013 - 10:53am
tags:
Tranzyme, earnings
Eli Lilly's Livalo: A Big Win For Patients And Investors
Seeking Alpha
Friday, March 29, 2013 - 10:52am
tags:
Eli Lilly, Livalo, HIV, Kowa, GSK, Merck, Pfizer, AstraZeneca
FDA Approves Novartis' TOBI Podhaler
Yahoo/Zacks
Friday, March 29, 2013 - 10:50am
tags:
FDA, Novartis, TOBI Podhaler, cystic fibrosis
Johnson & Johnson Waits for FDA Ruling on new Diabetes Drug
Motley Fool
Friday, March 29, 2013 - 10:49am
tags:
FDA, JNJ, diabetes, Invokana
Pfizer fails to win dismissal of shareholder class action lawsuit over Celebrex, Bextra
Reuters
Friday, March 29, 2013 - 10:47am
tags:
Pfizer, Celebrex, Bextra, Class Action Lawsuit
U.S. struggles with pharmaceutical goals in Asia trade talks
Reuters
Friday, March 29, 2013 - 10:46am
tags:
Asia
Should AstraZeneca and Bristol-Myers Squibb Get Married?
Motley Fool
Thursday, March 28, 2013 - 11:04am
tags:
Bristol-Myers Squibb, AstraZeneca, M&A
Amgen's And Vical's Melanoma Trials: Questions
Seeking Alpha
Thursday, March 28, 2013 - 10:38am
tags:
Amgen, Vical, melanoma
Aastrom's Shocking News And Future Potential
Seeking Alpha
Thursday, March 28, 2013 - 10:37am
tags:
Aastrom Biosciences
Repros testosterone drug hits main goals of key study
Reuters
Thursday, March 28, 2013 - 10:31am
tags:
Repros Therapeutics, testosterone, Androxal
Common Drug Has The Potential To Slow Aging, Boost Cancer Recovery
Forbes
Thursday, March 28, 2013 - 10:26am
tags:
metformin, Shionogi, Bristol-Myers Squibb, Santarus, Ranbaxy
How Much Will FDA Action On Invokana Affect Johnson And Johnson's Revenue And Stock Price?
Seeking Alpha
Thursday, March 28, 2013 - 10:23am
tags:
JNJ, FDA, Invokana, AstraZeneca, Bristol-Myers Squibb, Merck, Sanofi, Novo Nordisk, Novartis
Pfizer's Bosulif receives conditional marketing authorization from the EC
Yahoo/Fly on the Wall
Thursday, March 28, 2013 - 10:17am
tags:
Pfizer, Europe, Bosulif, chronic myelogenous leukemia
Lyrica's New Role Could Pay Off Big For Pfizer Investors
Seeking Alpha
Thursday, March 28, 2013 - 10:15am
tags:
Lyrica, Pfizer
Zoetis: Will This Successful Spin-off Mean More Spin-offs in the Industry?
Motley Fool
Thursday, March 28, 2013 - 10:14am
tags:
Zoetis, spinoffs, Pfizer, animal health
AP Pharma's drug for chemo-induced nausea denied approval
Reuters
Thursday, March 28, 2013 - 10:12am
tags:
chemotherapy-induced nausea and vomiting, AP Pharma, APF530
4 Stocks Dragging The Drugs Industry Downward
TheStreet.com
Thursday, March 28, 2013 - 8:52am
tags:
Novo Nordisk, Teva, Sanofi, Novartis
Trovagene launches easier test for HPV infection
Yahoo/AP
Thursday, March 28, 2013 - 8:48am
tags:
TrovaGene, HPV, cervical cancer
Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
Yahoo
Thursday, March 28, 2013 - 8:47am
tags:
blisibimod, Anthera, lupus

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.